Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02252757 · ClinicalTrials.gov registry record
Assess Measurements of Wireless Cardiac Output Device
A clinical trial, sponsored by Aventyn.
- Completed
- Registry status
- 25
- Enrollment target
NCT02252757: Completed study, sponsored by Aventyn.
NCT02252757 is a clinical trial that has completed, run by Aventyn. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02252757 has completed, sponsored by Aventyn.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Heart failure is a common cardiovascular problem which is increasing in both prevalence and incidence and associated with substantial morbidity and mortality. The management of heart failure patients is complex and has become a priority world over. Effective methods to keep heart failure patients out of the hospital are essential, both in the interests of the patient's health, as well as to reduce the burden on the health care system
Interventions
- DEVICE CoVa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-09 |
| Est. Completion | 2014-09 |
What the finished NCT02252757 record still lists
NCT02252757 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CoVa is the first listed.
NCT02252757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02252757 about?
NCT02252757 is a clinical study titled "Assess Measurements of Wireless Cardiac Output Device". Heart failure is a common cardiovascular problem which is increasing in both prevalence and incidence and associated with substantial morbidity and mortality. The management of heart failure patients is complex and has become a priority world over. Effective methods to keep heart failure patients ou...
What is the current status of trial NCT02252757?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2014-09. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02252757?
The interventions under investigation include: CoVa (DEVICE).
Who is sponsoring clinical trial NCT02252757?
This trial is sponsored by Aventyn, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia